An α-Gal-containing neoglycoprotein-based vaccine partially protects against murine cutaneous leishmaniasis caused by Leishmania major.
Iniguez E, Schocker NS, Subramaniam K, Portillo S, Montoya AL, Al-Salem WS, Torres CL, Rodriguez F, Moreira OC, Acosta-Serrano A, Michael K, Almeida IC, Maldonado RA.
Iniguez E, et al.
PLoS Negl Trop Dis. 2017 Oct 25;11(10):e0006039. doi: 10.1371/journal.pntd.0006039. eCollection 2017 Oct.
PLoS Negl Trop Dis. 2017.
PMID: 29069089
Free PMC article.